SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001427570-18-000087
Filing Date
2018-11-02
Accepted
2018-11-02 08:01:55
Documents
2
Period of Report
2018-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K oblnq3-18earnings8xk.htm 8-K 32356
2 EXHIBIT 99.1 oblnpressreleaseq32018.htm EX-99.1 163641
  Complete submission text file 0001427570-18-000087.txt   197312
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 181155531
SIC: 3841 Surgical & Medical Instruments & Apparatus